10468 related articles for article (PubMed ID: 10232365)
1. Reduced melanoma tumor formation in mice immunized with DNA expressing the melanoma-specific antigen gp100/pmel17.
Nawrath M; Pavlovic J; Dummet R; Schultz J; Strack B; Heinrich J; Moelling K
Leukemia; 1999 Apr; 13 Suppl 1():S48-51. PubMed ID: 10232365
[TBL] [Abstract][Full Text] [Related]
2. Memory and cellular immunity induced by a DNA vaccine encoding self antigen TPD52 administered with soluble GM-CSF.
Lewis JD; Sullivan LA; Byrne JA; de Riese W; Bright RK
Cancer Immunol Immunother; 2009 Aug; 58(8):1337-49. PubMed ID: 19169682
[TBL] [Abstract][Full Text] [Related]
3. In vivo responses to vaccination with Mage-b, GM-CSF and thioglycollate in a highly metastatic mouse breast tumor model, 4T1.
Gravekamp C; Leal B; Denny A; Bahar R; Lampkin S; Castro F; Kim SH; Moore D; Reddick R
Cancer Immunol Immunother; 2008 Jul; 57(7):1067-77. PubMed ID: 18094967
[TBL] [Abstract][Full Text] [Related]
4. Analysis of Pmel17/gp100 expression in primary human tissue specimens: implications for melanoma immuno- and gene-therapy.
Wagner SN; Wagner C; Schultewolter T; Goos M
Cancer Immunol Immunother; 1997 Jun; 44(4):239-47. PubMed ID: 9222283
[TBL] [Abstract][Full Text] [Related]
5. Development of an allogeneic whole-cell tumor vaccine expressing xenogeneic gp100 and its implementation in a phase II clinical trial in canine patients with malignant melanoma.
Alexander AN; Huelsmeyer MK; Mitzey A; Dubielzig RR; Kurzman ID; Macewen EG; Vail DM
Cancer Immunol Immunother; 2006 Apr; 55(4):433-42. PubMed ID: 15965647
[TBL] [Abstract][Full Text] [Related]
6. Effective immunotherapy of cancer by DNA vaccination.
Park JH; Kim CJ; Lee JH; Shin SH; Chung GH; Jang YS
Mol Cells; 1999 Aug; 9(4):384-91. PubMed ID: 10515601
[TBL] [Abstract][Full Text] [Related]
7. Long-term tumor growth suppression in mice immunized with naked DNA of the human tumor antigen mucin (MUC1).
Johnen H; Kulbe H; Pecher G
Cancer Immunol Immunother; 2001 Sep; 50(7):356-60. PubMed ID: 11676395
[TBL] [Abstract][Full Text] [Related]
8. Pmel17 initiates premelanosome morphogenesis within multivesicular bodies.
Berson JF; Harper DC; Tenza D; Raposo G; Marks MS
Mol Biol Cell; 2001 Nov; 12(11):3451-64. PubMed ID: 11694580
[TBL] [Abstract][Full Text] [Related]
9. [Effects of STAT3 antisense oligodeoxynucleotides on apoptosis and proliferation of mouse melanoma cell line B16].
Tang GS; Cai JM; Ni J; Xiang YS; Cui JG; Zhu D; Dong JR
Ai Zheng; 2006 Mar; 25(3):269-74. PubMed ID: 16536977
[TBL] [Abstract][Full Text] [Related]
10. Multiprobe fluorescence imaging and microspectrofluorimetry of cell transformation and differentiation: implications in terms of applied biochemistry and biotechnology.
Kohen E; Gatt S; Schachtschabel A; Schachtschabel DO; Kohen C; Agmon V; Hirschberg JG; Monti M; Roisen F
Biotechnol Appl Biochem; 1999 Jun; 29(3):191-205. PubMed ID: 10334948
[TBL] [Abstract][Full Text] [Related]
11. Use of murine models of cytokine-secreting tumor vaccines to study feasibility and toxicity issues critical to designing clinical trials.
Jaffee EM; Lazenby A; Meurer J; Marshall F; Hauda KM; Counts C; Hurwitz H; Simons JW; Levitsky HI; Pardoll DM
J Immunother Emphasis Tumor Immunol; 1995 Jul; 18(1):1-9. PubMed ID: 8535565
[No Abstract] [Full Text] [Related]
12. Serum levels of soluble cell adhesion molecules (ICAM-1, VCAM-1, E-selectin) and of cytokine TNF-alpha increase during interleukin-2 therapy.
Fortis C; Galli L; Consogno G; Citterio G; Matteucci P; Scaglietti U; Bucci E
Clin Immunol Immunopathol; 1995 Aug; 76(2):142-7. PubMed ID: 7542185
[TBL] [Abstract][Full Text] [Related]
13. Supermelanotic hybrids between mouse teratocarcinoma and mouse melanoma cells.
Watanabe T
Exp Cell Res; 1984 Oct; 154(2):625-31. PubMed ID: 6479244
[TBL] [Abstract][Full Text] [Related]
14. [Anti-ganglioside monoclonal antibodies possess strong anti-tumor activities].
Tai T
Seikagaku; 1987 Sep; 59(9):1031-4. PubMed ID: 3437166
[No Abstract] [Full Text] [Related]
15. Thymosin-inducible lymphocytes in the peripheral blood of patients with malignant melanoma.
Byrom NA; Campbell MA; Dean AJ; Timlin DM; Volkers C; Bodenham DC; Hobbs JR
Cancer Treat Rep; 1978 Nov; 62(11):1769-74. PubMed ID: 310343
[TBL] [Abstract][Full Text] [Related]
16. The melanocytotoxicity of gamma-L-glutaminyl-4-hydroxybenzene: a study of the pigmented cells in the mouse eye.
Koo EH; Burger PC; Vogel FS
Am J Pathol; 1981 Jan; 102(1):40-8. PubMed ID: 7468758
[TBL] [Abstract][Full Text] [Related]
17. [Modern biomaterials as hemostatic dressings in kidney nephron sparing surgery (NSS)--murine model. A preliminary report].
Nowacki M; Jundziłł A; Bieniek M; Kowalczyk T; Kloskowski T; Drewa T
Polim Med; 2012; 42(1):35-43. PubMed ID: 22783731
[TBL] [Abstract][Full Text] [Related]
18. Cutaneous biology of gammadelta T cells.
Girardi M
Adv Dermatol; 2004; 20():203-15. PubMed ID: 15544201
[TBL] [Abstract][Full Text] [Related]
19. Differential expression of CD44(S) and variant isoforms v3, v10 in three-dimensional cultures of mouse melanoma cell lines.
Shiras A; Bhosale A; Patekar A; Shepal V; Shastry P
Clin Exp Metastasis; 2002; 19(5):445-55. PubMed ID: 12198773
[TBL] [Abstract][Full Text] [Related]
20. Long-term survival after ruthenium plaque radiotherapy for uveal melanoma. A meta-analysis of studies including 1,066 patients.
Seregard S
Acta Ophthalmol Scand; 1999 Aug; 77(4):414-7. PubMed ID: 10463412
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
